P53 and mitochondrial function in neurons

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 8, 2014, Pages 1186-1197

  Wang, David B ^a   Kinoshita, Chizuru ^a   Kinoshita, Yoshito ^a   Morrison, Richard S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Mitochondria; Mitochondrial dynamics; Mitophagy; P53

Indexed keywords

ANTIOXIDANT; CASPASE; CYTOCHROME C; MITOCHONDRIAL PROTEIN; PROTEIN P53;

APOPTOSIS; AUTOPHAGY; BIOGENESIS; CELL DEATH; CELL FUNCTION; CELL METABOLISM; CELL SURVIVAL; DNA DAMAGE; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL VOLUME; MITOCHONDRION; MITOPHAGY; NECROSIS; NERVE CELL; NERVE DEGENERATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; BRAIN CELL; CELL DESTRUCTION; CELL FATE; DNA METABOLISM; ENERGY YIELD; IMMUNOREACTIVITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION;

APOPTOSIS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOPHAGY; P53;

ANIMALS; APOPTOSIS; AUTOPHAGY; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; NEURONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903269985     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.12.015     Document Type: Review

References (189)

1. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
2. Hu W., Feng Z., Levine A.J. The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer 2012, 3:199-208.
3. Vlatkovic N., Boyd M.T., Rubbi C.P. Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy. Cell. Mol. Life Sci. 2013, (epub ahead of press).
4. Rufini A., Tucci P., Celardo I., Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013, 32:5129-5143.
5. Vousden K.H., Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
6. Lanni C., Racchi M., Memo M., Govoni S., Uberti D. p53 at the crossroads between cancer and neurodegeneration. Free Radic. Biol. Med. 2012, 52:1727-1733.
7. Berkers C.R., Maddocks O.D., Cheung E.C., Mor I., Vousden K.H. Metabolic regulation by p53 family members. Cell Metab. 2013, 18:617-633.
8. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci. 2004, 95:7-11.
9. Brady C.A., Attardi L.D. p53 at a glance. J. Cell Sci. 2010, 123:2527-2532.
10. Stambolsky P., Weisz L., Shats I., Klein Y., Goldfinger N., Oren M., Rotter V. Regulation of AIF expression by p53. Cell Death Differ. 2006, 13:2140-2149.
11. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9:1799-1805.
12. Sugars K.L., Budhram-Mahadeo V., Packham G., Latchman D.S. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res. 2001, 29:4530-4540.
13. Pietrzak M., Puzianowska-Kuznicka M. p53-Dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol. Chem. 2008, 389:383-393.
14. Morrison R.S., Kinoshita Y., Johnson M.D., Guo W., Garden G.A. p53-Dependent cell death signaling in neurons. Neurochem. Res. 2003, 28:15-27.
15. Cregan S.P., Arbour N.A., Maclaurin J.G., Callaghan S.M., Fortin A., Cheung E.C., Guberman D.S., Park D.S., Slack R.S. p53 activation domain 1 is essential for PUMA upregulation and p53-mediated neuronal cell death. J. Neurosci. 2004, 24:10003-10012.
16. Culmsee C., Mattson M.P. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 2005, 331:761-777.
17. Uo T., Kinoshita Y., Morrison R.S. Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons. J. Neurosci. 2007, 27:12198-12210.
18. Niizuma K., Endo H., Chan P.H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem. 2009, 109(Suppl. 1):133-138.
19. Vaseva A.V., Moll U.M. The mitochondrial p53 pathway. Biochim. Biophys. Acta 2009, 1787:414-420.
20. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
21. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 2000, 275:16202-16212.
22. Sansome C., Zaika A., Marchenko N.D., Moll U.M. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett. 2001, 488:110-115.
23. Dumont P., Leu J.I., Della Pietra A.C., George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003, 33:357-365.
24. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
25. Wood K.A., Youle R.J. The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 1995, 15:5851-5857.
26. Hughes P.E., Alexi T., Yoshida T., Schreiber S.S., Knusel B. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience 1996, 74:1143-1160.
27. Sakhi S., Sun N., Wing L.L., Mehta P., Schreiber S.S. Nuclear accumulation of p53 protein following kainic acid-induced seizures. Neuroreport 1996, 7:493-496.
28. LaFerla F.M., Hall C.K., Ngo L., Jay G. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J. Clin. Invest. 1996, 98:1626-1632.
29. Sadoul R., Quiquerez A.L., Martinou I., Fernandez P.A., Martinou J.C. p53 protein in sympathetic neurons: cytoplasmic localization and no apparent function in apoptosis. J. Neurosci. Res. 1996, 43:594-601.
30. Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 1998, 21:799-811.
31. Endo H., Kamada H., Nito C., Nishi T., Chan P.H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 2006, 26:7974-7983.
32. Nair V.D., McNaught K.S., Gonzalez-Maeso J., Sealfon S.C., Olanow C.W. p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J. Biol. Chem. 2006, 281:39550-39560.
33. Nijboer C.H., Heijnen C.J., Groenendaal F., May M.J., van Bel F., Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008, 39:2129-2137.
34. Martin L.J., Liu Z., Pipino J., Chestnut B., Landek M.A. Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex. Cereb. Cortex 2009, 19:1273-1293.
35. Nijboer C.H., Heijnen C.J., van der Kooij M.A., Zijlstra J., van Velthoven C.T., Culmsee C., van Bel F., Hagberg H., Kavelaars A. Targeting the p53 pathway to protect the neonatal ischemic brain. Ann. Neurol. 2011, 70:255-264.
36. Gomez-Sanchez J.C., Delgado-Esteban M., Rodriguez-Hernandez I., Sobrino T., Perez de la Ossa N., Reverte S., Bolanos J.P., Gonzalez-Sarmiento R., Castillo J., Almeida A. The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke. J. Exp. Med. 2011, 208:429-437.
37. Dong X.X., Wang Y.R., Qin S., Liang Z.Q., Liu B.H., Qin Z.H., Wang Y. p53 mediates autophagy activation and mitochondria dysfunction in kainic acid-induced excitotoxicity in primary striatal neurons. Neuroscience 2012, 207:52-64.
38. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285:1733-1737.
39. Strom E., Sathe S., Komarov P.G., Chernova O.B., Pavlovska I., Shyshynova I., Bosykh D.A., Burdelya L.G., Macklis R.M., Skaliter R., Komarova E.A., Gudkov A.V. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat. Chem. Biol. 2006, 2:474-479.
40. Komarova E.A., Neznanov N., Komarov P.G., Chernov M.V., Wang K., Gudkov A.V. p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J. Biol. Chem. 2003, 278:15465-15468.
41. Hoagland M.S., Hoagland E.M., Swanson H.I. The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor. J. Pharmacol. Exp. Ther. 2005, 314:603-610.
42. Sohn D., Graupner V., Neise D., Essmann F., Schulze-Osthoff K., Janicke R.U. Pifithrin-alpha protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53. Cell Death Differ. 2009, 16:869-878.
43. Leu J.I., Pimkina J., Frank A., Murphy M.E., George D.L. A small molecule inhibitor of inducible heat shock protein 70. Mol. Cell 2009, 36:15-27.
44. Heyne K., Schmitt K., Mueller D., Armbruester V., Mestres P., Roemer K. Resistance of mitochondrial p53 to dominant inhibition. Mol. Cancer 2008, 7:54.
45. Sakamuro D., Sabbatini P., White E., Prendergast G.C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 1997, 15:887-898.
46. Venot C., Maratrat M., Dureuil C., Conseiller E., Bracco L., Debussche L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 1998, 17:4668-4679.
47. Zhu J., Jiang J., Zhou W., Zhu K., Chen X. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 1999, 18:2149-2155.
48. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
49. Schuler M., Green D.R. Transcription, apoptosis and p53: catch-22. Trends Genet. 2005, 21:182-187.
50. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., St Clair D.K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65:3745-3750.
51. Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S., Moll U.M. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012, 149:1536-1548.
52. Crumrine R.C., Thomas A.L., Morgan P.F. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 1994, 14:887-891.
53. Ferecatu I., Bergeaud M., Rodriguez-Enfedaque A., Le Floch N., Oliver L., Rincheval V., Renaud F., Vallette F.M., Mignotte B., Vayssiere J.L. Mitochondrial localization of the low level p53 protein in proliferative cells. Biochem. Biophys. Res. Commun. 2009, 387:772-777.
54. Montero J., Dutta C., van Bodegom D., Weinstock D., Letai A. p53 regulates a non-apoptotic death induced by ROS. Cell Death Differ. 2013, 20:1465-1474.
55. Feng Z., Hu W., de Stanchina E., Teresky A.K., Jin S., Lowe S., Levine A.J. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007, 67:3043-3053.
56. Lomonosova E., Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008, 27(Suppl. 1):S2-S19.
57. Maiuri M.C., Galluzzi L., Morselli E., Kepp O., Malik S.A., Kroemer G. Autophagy regulation by p53. Curr. Opin. Cell Biol. 2010, 22:181-185.
58. Okamura S., Arakawa H., Tanaka T., Nakanishi H., Ng C.C., Taya Y., Monden M., Nakamura Y. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 2001, 8:85-94.
59. Seillier M., Peuget S., Gayet O., Gauthier C., N'Guessan P., Monte M., Carrier A., Iovanna J.L., Dusetti N.J. TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death. Cell Death Differ. 2012, 19:1525-1535.
60. Vanlandingham J.W., Tassabehji N.M., Somers R.C., Levenson C.W. Expression profiling of p53-target genes in copper-mediated neuronal apoptosis. Neuromolecular Med. 2005, 7:311-324.
61. Crighton D., Wilkinson S., O'Prey J., Syed N., Smith P., Harrison P.R., Gasco M., Garrone O., Crook T., Ryan K.M. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006, 126:121-134.
62. Mah L.Y., O'Prey J., Baudot A.D., Hoekstra A., Ryan K.M. DRAM-1 encodes multiple isoforms that regulate autophagy. Autophagy 2012, 8:18-28.
63. Zhang X.D., Wang Y., Wang Y., Zhang X., Han R., Wu J.C., Liang Z.Q., Gu Z.L., Han F., Fukunaga K., Qin Z.H. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 2009, 5:339-350.
64. Wang Y., Dong X.X., Cao Y., Liang Z.Q., Han R., Wu J.C., Gu Z.L., Qin Z.H. p53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms. Eur. J. Neurosci. 2009, 30:2258-2270.
65. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., Criollo A., Morselli E., Zhu C., Harper F., Nannmark U., Samara C., Pinton P., Vicencio J.M., Carnuccio R., Moll U.M., Madeo F., Paterlini-Brechot P., Rizzuto R., Szabadkai G., Pierron G., Blomgren K., Tavernarakis N., Codogno P., Cecconi F., Kroemer G. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10:676-687.
66. Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z., Oren M. p53-Dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18511-18516.
67. Kreiner G., Bierhoff H., Armentano M., Rodriguez-Parkitna J., Sowodniok K., Naranjo J.R., Bonfanti L., Liss B., Schutz G., Grummt I., Parlato R. A neuroprotective phase precedes striatal degeneration upon nucleolar stress. Cell Death Differ. 2013, 20:1455-1464.
68. Jaeger P.A., Wyss-Coray T. All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Mol. Neurodegener. 2009, 4:16.
69. Ashrafi G., Schwarz T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013, 20:31-42.
70. Feng D., Liu L., Zhu Y., Chen Q. Molecular signaling toward mitophagy and its physiological significance. Exp. Cell Res. 2013, 319:1697-1705.
71. Gomes L.C., Scorrano L. Mitochondrial morphology in mitophagy and macroautophagy. Biochim. Biophys. Acta 2013, 1833:205-212.
72. Grenier K., McLelland G.L., Fon E.A. Parkin- and PINK1-dependent mitophagy in neurons: will the real pathway please stand up?. Front. Neurol. 2013, 4:100.
73. Zhang C., Lin M., Wu R., Wang X., Yang B., Levine A.J., Hu W., Feng Z. Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16259-16264.
74. Wang D.B., Garden G.A., Kinoshita C., Wyles C., Babazadeh N., Sopher B., Kinoshita Y., Morrison R.S. Declines in Drp1 and parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death. J. Neurosci. 2013, 33:1357-1365.
75. da Costa C.A., Sunyach C., Giaime E., West A., Corti O., Brice A., Safe S., Abou-Sleiman P.M., Wood N.W., Takahashi H., Goldberg M.S., Shen J., Checler F. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat. Cell Biol. 2009, 11:1370-1375.
76. Sunico C.R., Nakamura T., Rockenstein E., Mante M., Adame A., Chan S.F., Newmeyer T.F., Masliah E., Nakanishi N., Lipton S.A. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease. Mol. Neurodegener. 2013, 8:29.
77. Hoshino A., Mita Y., Okawa Y., Ariyoshi M., Iwai-Kanai E., Ueyama T., Ikeda K., Ogata T., Matoba S. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat. Commun. 2013, 4:2308.
78. Bensaad K., Cheung E.C., Vousden K.H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009, 28:3015-3026.
79. Kim H., Rafiuddin-Shah M., Tu H.C., Jeffers J.R., Zambetti G.P., Hsieh J.J., Cheng E.H. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 2006, 8:1348-1358.
80. Zhang J., Ney P.A. Mechanisms and biology of B-cell leukemia/lymphoma 2/adenovirus E1B interacting protein 3 and Nip-like protein X. Antioxid. Redox Signal. 2011, 14:1959-1969.
81. Feng X., Liu X., Zhang W., Xiao W. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J. 2011, 30:3397-3415.
82. Fei P., Wang W., Kim S.H., Wang S., Burns T.F., Sax J.K., Buzzai M., Dicker D.T., McKenna W.G., Bernhard E.J., El-Deiry W.S. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 2004, 6:597-609.
83. Zhang S., Zhang Z., Sandhu G., Ma X., Yang X., Geiger J.D., Kong J. Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res. 2007, 1138:221-230.
84. Prabhakaran K., Li L., Zhang L., Borowitz J.L., Isom G.E. Upregulation of BNIP3 and translocation to mitochondria mediates cyanide-induced apoptosis in cortical cells. Neuroscience 2007, 150:159-167.
85. Zhao S.T., Chen M., Li S.J., Zhang M.H., Li B.X., Das M., Bean J.C., Kong J.M., Zhu X.H., Gao T.M. Mitochondrial BNIP3 upregulation precedes endonuclease G translocation in hippocampal neuronal death following oxygen-glucose deprivation. BMC Neurosci. 2009, 10:113.
86. Yeh S.H., Ou L.C., Gean P.W., Hung J.J., Chang W.C. Selective inhibition of early-but not late-expressed HIF-1alpha is neuroprotective in rats after focal ischemic brain damage. Brain Pathol. 2011, 21:249-262.
87. Rui Y., Ke K., Li L., Zheng H., Xu W., Tan X., Cao J., Wu X., Cui G., Zhao G., Gao Y., Cao M. Up-regulated expression of Bnip3L after intracerebral hemorrhage in adult rats. J. Mol. Histol. 2013, 44:497-505.
88. Miyamoto Y., Kitamura N., Nakamura Y., Futamura M., Miyamoto T., Yoshida M., Ono M., Ichinose S., Arakawa H. Possible existence of lysosome-like organella within mitochondria and its role in mitochondrial quality control. PLoS One 2011, 6:e16054.
89. Kitamura N., Nakamura Y., Miyamoto Y., Miyamoto T., Kabu K., Yoshida M., Futamura M., Ichinose S., Arakawa H. Mieap, a p53-inducible protein, controls mitochondrial quality by repairing or eliminating unhealthy mitochondria. PLoS One 2011, 6:e16060.
90. Nakamura Y., Kitamura N., Shinogi D., Yoshida M., Goda O., Murai R., Kamino H., Arakawa H. BNIP3 and NIX mediate Mieap-induced accumulation of lysosomal proteins within mitochondria. PLoS One 2012, 7:e30767.
91. Miyamoto T., Kitamura N., Ono M., Nakamura Y., Yoshida M., Kamino H., Murai R., Yamada T., Arakawa H. Identification of 14-3-3gamma as a Mieap-interacting protein and its role in mitochondrial quality control. Sci. Rep. 2012, 2:379.
92. Radhakrishnan V.M., Putnam C.W., Qi W., Martinez J.D. p53 suppresses expression of the 14-3-3 gamma oncogene. BMC Cancer 2011, 11:378.
93. Lehar S.M., Nacht M., Jacks T., Vater C.A., Chittenden T., Guild B.C. Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells. Oncogene 1996, 12:1181-1187.
94. Zhao Y.G., Zhao H., Miao L., Wang L., Sun F., Zhang H. The p53-induced gene Ei24 is an essential component of the basal autophagy pathway. J. Biol. Chem. 2012, 287:42053-42063.
95. Zhao X., Ayer R.E., Davis S.L., Ames S.J., Florence B., Torchinsky C., Liou J.S., Shen L., Spanjaard R.A. Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized Bcl-2-binding protein which is associated with suppression of breast cancer invasiveness. Cancer Res. 2005, 65:2125-2129.
96. Bahk Y.Y., Lee J., Cho I.H., Lee H.W. An analysis of an interactome for apoptosis factor, Ei24/PIG8, using the inducible expression system and shotgun proteomics. J. Proteome Res. 2010, 9:5270-5283.
97. Merkwirth C., Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta 2009, 1793:27-32.
98. Park J.Y., Wang P.Y., Matsumoto T., Sung H.J., Ma W., Choi J.W., Anderson S.A., Leary S.C., Balaban R.S., Kang J.G., Hwang P.M. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ. Res. 2009, 105:705-712. (711 pp. following 712).
99. Wong T.S., Rajagopalan S., Freund S.M., Rutherford T.J., Andreeva A., Townsley F.M., Petrovich M., Fersht A.R. Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53. Nucleic Acids Res. 2009, 37:6765-6783.
100. Wong T.S., Rajagopalan S., Townsley F.M., Freund S.M., Petrovich M., Loakes D., Fersht A.R. Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53. Nucleic Acids Res. 2009, 37:568-581.
101. Yoshida Y., Izumi H., Torigoe T., Ishiguchi H., Itoh H., Kang D., Kohno K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res. 2003, 63:3729-3734.
102. Saleem A., Hood D.A. Acute exercise induces tumour suppressor protein p53 translocation to the mitochondria and promotes a p53-Tfam-mitochondrial DNA complex in skeletal muscle. J. Physiol. 2013, 591:3625-3636.
103. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005, 24:3482-3492.
104. de Souza-Pinto N.C., Harris C.C., Bohr V.A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 2004, 23:6559-6568.
105. Lebedeva M.A., Eaton J.S., Shadel G.S. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta 2009, 1787:328-334.
106. Kulawiec M., Ayyasamy V., Singh K.K. p53 regulates mtDNA copy number and mitocheckpoint pathway. J. Carcinog. 2009, 8:8.
107. Tanaka H., Arakawa H., Yamaguchi T., Shiraishi K., Fukuda S., Matsui K., Takei Y., Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000, 404:42-49.
108. Pontarin G., Ferraro P., Bee L., Reichard P., Bianchi V. Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13302-13307.
109. Bourdon A., Minai L., Serre V., Jais J.P., Sarzi E., Aubert S., Chretien D., de Lonlay P., Paquis-Flucklinger V., Arakawa H., Nakamura Y., Munnich A., Rotig A. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 2007, 39:776-780.
110. Chabes A.L., Pfleger C.M., Kirschner M.W., Thelander L. Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3925-3929.
111. Almeida A. Regulation of APC/C-Cdh1 and its function in neuronal survival. Mol. Neurobiol. 2012, 46:547-554.
112. Bergeaud M., Mathieu L., Guillaume A., Moll U.M., Mignotte B., Le Floch N., Vayssiere J.L., Rincheval V. Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F 1F 0-ATP synthase. Cell Cycle 2013, 12.
113. Austin S., St-Pierre J. PGC1alpha and mitochondrial metabolism-emerging concepts and relevance in ageing and neurodegenerative disorders. J. Cell Sci. 2012, 125:4963-4971.
114. Wenz T. Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion 2013, 13:134-142.
115. Tsunemi T., La Spada A.R. PGC-1alpha at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond. Prog. Neurobiol. 2012, 97:142-151.
116. Saleem A., Adhihetty P.J., Hood D.A. Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol. Genomics 2009, 37:58-66.
117. Sahin E., Colla S., Liesa M., Moslehi J., Muller F.L., Guo M., Cooper M., Kotton D., Fabian A.J., Walkey C., Maser R.S., Tonon G., Foerster F., Xiong R., Wang Y.A., Shukla S.A., Jaskelioff M., Martin E.S., Heffernan T.P., Protopopov A., Ivanova E., Mahoney J.E., Kost-Alimova M., Perry S.R., Bronson R., Liao R., Mulligan R., Shirihai O.S., Chin L., DePinho R.A. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-365.
118. Aquilano K., Baldelli S., Pagliei B., Cannata S.M., Rotilio G., Ciriolo M.R. p53 orchestrates the PGC-1alpha-mediated antioxidant response upon mild redox and metabolic imbalance. Antioxid. Redox Signal. 2013, 18:386-399.
119. Villeneuve C., Guilbeau-Frugier C., Sicard P., Lairez O., Ordener C., Duparc T., De Paulis D., Couderc B., Spreux-Varoquaux O., Tortosa F., Garnier A., Knauf C., Valet P., Borchi E., Nediani C., Gharib A., Ovize M., Delisle M.B., Parini A., Mialet-Perez J. p53-PGC-1alpha pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid. Redox Signal. 2013, 18:5-18.
120. Sen N., Satija Y.K., Das S. PGC-1alpha, a key modulator of p53, promotes cell survival upon metabolic stress. Mol. Cell 2011, 44:621-634.
121. Aquilano K., Vigilanza P., Baldelli S., Pagliei B., Rotilio G., Ciriolo M.R. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J. Biol. Chem. 2010, 285:21590-21599.
122. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9:691-700.
123. Shen L., Sun X., Fu Z., Yang G., Li J., Yao L. The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy. Clin. Cancer Res. 2012, 18:1561-1567.
124. Contractor T., Harris C.R. p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res. 2012, 72:560-567.
125. Hu W., Zhang C., Wu R., Sun Y., Levine A., Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7455-7460.
126. Suzuki S., Tanaka T., Poyurovsky M.V., Nagano H., Mayama T., Ohkubo S., Lokshin M., Hosokawa H., Nakayama T., Suzuki Y., Sugano S., Sato E., Nagao T., Yokote K., Tatsuno I., Prives C. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7461-7466.
127. Okamura S., Ng C.C., Koyama K., Takei Y., Arakawa H., Monden M., Nakamura Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol. Res. 1999, 11:281-285.
128. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
129. Zhou S., Kachhap S., Singh K.K. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 2003, 18:287-292.
130. Vahsen N., Cande C., Briere J.J., Benit P., Joza N., Larochette N., Mastroberardino P.G., Pequignot M.O., Casares N., Lazar V., Feraud O., Debili N., Wissing S., Engelhardt S., Madeo F., Piacentini M., Penninger J.M., Schagger H., Rustin P., Kroemer G. AIF deficiency compromises oxidative phosphorylation. EMBO J. 2004, 23:4679-4689.
131. Yoon K.A., Nakamura Y., Arakawa H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 2004, 49:134-140.
132. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
133. Jiang P., Du W., Wang X., Mancuso A., Gao X., Wu M., Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 2011, 13:310-316.
134. Herrero-Mendez A., Almeida A., Fernandez E., Maestre C., Moncada S., Bolanos J.P. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol. 2009, 11:747-752.
135. Hoshino A., Matoba S., Iwai-Kanai E., Nakamura H., Kimata M., Nakaoka M., Katamura M., Okawa Y., Ariyoshi M., Mita Y., Ikeda K., Ueyama T., Okigaki M., Matsubara H. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J. Mol. Cell. Cardiol. 2012, 52:175-184.
136. Xiang H., Hochman D.W., Saya H., Fujiwara T., Schwartzkroin P.A., Morrison R.S. Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 1996, 16:6753-6765.
137. Rodriguez-Rodriguez P., Fernandez E., Almeida A., Bolanos J.P. Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ. 2012, 19:1582-1589.
138. Katsel P., Tan W., Fam P., Purohit D.P., Haroutunian V. Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer's disease. PLoS One 2013, 8:e68361.
139. Veal E.A., Day A.M., Morgan B.A. Hydrogen peroxide sensing and signaling. Mol. Cell 2007, 26:1-14.
140. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., Chumakov P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004, 304:596-600.
141. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., Ichimiya M., Sengupta S., Mechanic L., Okamura S., Hofseth L.J., Moake M., Nagashima M., Forrester K.S., Harris C.C. p53-Induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64:2350-2356.
142. Cano C.E., Gommeaux J., Pietri S., Culcasi M., Garcia S., Seux M., Barelier S., Vasseur S., Spoto R.P., Pebusque M.J., Dusetti N.J., Iovanna J.L., Carrier A. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res. 2009, 69:219-226.
143. Esworthy R.S., Ho Y.S., Chu F.F. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch. Biochem. Biophys. 1997, 340:59-63.
144. Mari M., Morales A., Colell A., Garcia-Ruiz C., Kaplowitz N., Fernandez-Checa J.C. Mitochondrial glutathione: features, regulation and role in disease. Biochim. Biophys. Acta 2013, 1830:3317-3328.
145. Holley A.K., Dhar S.K., St Clair D.K. Manganese superoxide dismutase vs. p53: regulation of mitochondrial ROS. Mitochondrion 2010, 10:649-661.
146. Pani G., Galeotti T. Role of MnSOD and p66shc in mitochondrial response to p53. Antioxid. Redox Signal. 2011, 15:1715-1727.
147. Dhar S.K., Xu Y., St Clair D.K. Nuclear factor kappaB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene. J. Biol. Chem. 2010, 285:9835-9846.
148. Bakthavatchalu V., Dey S., Xu Y., Noel T., Jungsuwadee P., Holley A.K., Dhar S.K., Batinic-Haberle I., St Clair D.K. Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Polgamma against UV-induced inactivation. Oncogene 2012, 31:2129-2139.
149. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature 1997, 389:300-305.
150. Liu G., Chen X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 2002, 21:7195-7204.
151. Maxwell S.A., Rivera A. Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas. J. Biol. Chem. 2003, 278:9784-9789.
152. Liu Y., Borchert G.L., Donald S.P., Surazynski A., Hu C.A., Weydert C.J., Oberley L.W., Phang J.M. MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 2005, 26:1335-1342.
153. Gertz M., Steegborn C. The lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor?. Antioxid. Redox Signal. 2010, 13:1417-1428.
154. Su K., Bourdette D., Forte M. Mitochondrial dysfunction and neurodegeneration in multiple sclerosis. Front. Physiol. 2013, 4:169.
155. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., Lanfrancone L., Pelicci P.G. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
156. Trinei M., Giorgio M., Cicalese A., Barozzi S., Ventura A., Migliaccio E., Milia E., Padura I.M., Raker V.A., Maccarana M., Petronilli V., Minucci S., Bernardi P., Lanfrancone L., Pelicci P.G. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002, 21:3872-3878.
157. Kim C.S., Jung S.B., Naqvi A., Hoffman T.A., DeRicco J., Yamamori T., Cole M.P., Jeon B.H., Irani K. p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc. Circ. Res. 2008, 103:1441-1450.
158. Chatoo W., Abdouh M., David J., Champagne M.P., Ferreira J., Rodier F., Bernier G. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J. Neurosci. 2009, 29:529-542.
159. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat. Med. 2005, 11:1306-1313.
160. Forsberg K., Wuttke A., Quadrato G., Chumakov P.M., Wizenmann A., Di Giovanni S. The tumor suppressor p53 fine-tunes reactive oxygen species levels and neurogenesis via PI3 kinase signaling. J. Neurosci. 2013, 33:14318-14330.
161. Barone E., Cenini G., Sultana R., Di Domenico F., Fiorini A., Perluigi M., Noel T., Wang C., Mancuso C., St Clair D.K., Butterfield D.A. Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. Antioxid. Redox Signal. 2012, 16:1407-1420.
162. Chatoo W., Abdouh M., Bernier G. p53 pro-oxidant activity in the central nervous system: implication in aging and neurodegenerative diseases. Antioxid. Redox Signal. 2011, 15:1729-1737.
163. Sompol P., Ittarat W., Tangpong J., Chen Y., Doubinskaia I., Batinic-Haberle I., Abdul H.M., Butterfield D.A., St Clair D.K. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury. Neuroscience 2008, 153:120-130.
164. Zhou D., Zhan C., Zhong Q., Li S. Upregulation of sestrin-2 expression via P53 protects against 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity. J. Mol. Neurosci. 2013, 51:967-975.
165. Su K.G., Savino C., Marracci G., Chaudhary P., Yu X., Morris B., Galipeau D., Giorgio M., Forte M., Bourdette D. Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis. Eur. J. Neurosci. 2012, 35:562-571.
166. Su K., Bourdette D., Forte M. Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges. Front. Physiol. 2012, 3:285.
167. Smith W.W., Norton D.D., Gorospe M., Jiang H., Nemoto S., Holbrook N.J., Finkel T., Kusiak J.W. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. J. Cell Biol. 2005, 169:331-339.
168. Brown J.E., Zeiger S.L., Hettinger J.C., Brooks J.D., Holt B., Morrow J.D., Musiek E.S., Milne G., McLaughlin B. Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning. J. Neurosci. 2010, 30:5242-5252.
169. DuBoff B., Feany M., Gotz J. Why size matters - balancing mitochondrial dynamics in Alzheimer's disease. Trends Neurosci. 2013, 36:325-335.
170. Itoh K., Nakamura K., Iijima M., Sesaki H. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol. 2013, 23:64-71.
171. McInnes J. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl. Neurodegener. 2013, 2:12.
172. Parone P.A., Da Cruz S., Tondera D., Mattenberger Y., James D.I., Maechler P., Barja F., Martinou J.C. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS One 2008, 3:e3257.
173. Uo T., Dworzak J., Kinoshita C., Inman D.M., Kinoshita Y., Horner P.J., Morrison R.S. Drp1 levels constitutively regulate mitochondrial dynamics and cell survival in cortical neurons. Exp. Neurol. 2009, 218:274-285.
174. Kageyama Y., Zhang Z., Roda R., Fukaya M., Wakabayashi J., Wakabayashi N., Kensler T.W., Reddy P.H., Iijima M., Sesaki H. Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J. Cell Biol. 2012, 197:535-551.
175. DuBoff B., Gotz J., Feany M.B. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 2012, 75:618-632.
176. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., Graber S., Kovacs I., Lee W.D., Waggoner J., Cui J., White A.D., Bossy B., Martinou J.C., Youle R.J., Lipton S.A., Ellisman M.H., Perkins G.A., Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006, 25:3900-3911.
177. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. 2008, 105:19318-19323.
178. Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 2008, 9:505-518.
179. Liot G., Bossy B., Lubitz S., Kushnareva Y., Sejbuk N., Bossy-Wetzel E. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ. 2009, 16:899-909.
180. Twig G., Elorza A., Molina A.J., Mohamed H., Wikstrom J.D., Walzer G., Stiles L., Haigh S.E., Katz S., Las G., Alroy J., Wu M., Py B.F., Yuan J., Deeney J.T., Corkey B.E., Shirihai O.S. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008, 27:433-446.
181. Chen H., Vermulst M., Wang Y.E., Chomyn A., Prolla T.A., McCaffery J.M., Chan D.C. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010, 141:280-289.
182. Chen H., Chan D.C. Emerging functions of mammalian mitochondrial fusion and fission. Hum. Mol. Genet. 2005, 14(Spec No. 2):R283-R289.
183. Wang W., Cheng X., Lu J., Wei J., Fu G., Zhu F., Jia C., Zhou L., Xie H., Zheng S. Mitofusin-2 is a novel direct target of p53. Biochem. Biophys. Res. Commun. 2010, 400:587-592.
184. Li J., Donath S., Li Y., Qin D., Prabhakar B.S., Li P. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet. 2010, 6:e1000795.
185. Wang J.X., Jiao J.Q., Li Q., Long B., Wang K., Liu J.P., Li Y.R., Li P.F. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 2011, 17:71-78.
186. Cereghetti G.M., Stangherlin A., Martins de Brito O., Chang C.R., Blackstone C., Bernardi P., Scorrano L. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15803-15808.
187. Guo X., Disatnik M.H., Monbureau M., Shamloo M., Mochly-Rosen D., Qi X. Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J. Clin. Invest. 2013, 123:5371-5388.
188. Smith A.C., Blackshaw J.A., Robinson A.J. MitoMiner: a data warehouse for mitochondrial proteomics data. Nucleic Acids Res. 2012, 40:D1160-D1167.
189. Mootha V.K., Bunkenborg J., Olsen J.V., Hjerrild M., Wisniewski J.R., Stahl E., Bolouri M.S., Ray H.N., Sihag S., Kamal M., Patterson N., Lander E.S., Mann M. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 2003, 115:629-640.